Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000
Mandate

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000

October 03, 2018 Banking and Finance

Vinge has advised Nordea Bank AB (publ) (“Nordea”) in connection with a tender offer and issue of new bonds with an aggregate transaction value of SEK 2,705,000,000.

Vinge has advised Nordea in connection with Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) tender offer and subsequent repurchase of its previously issued senior and unsecured bonds up to a total amount of SEK 1,205,000,000 (the “Tender Offer”) and its issuance of new senior unsecured bonds with a framework amount of up to SEK 1,500,000,000 (the “New Bonds”).

The initial amount issued under the New Bonds amounts to SEK 1,000,000,000 per 3 October 2018. Nordea was mandated as sole arranger, bookrunner and issuing agent in connection with the New Bonds and as dealer manager, sole bookrunner and tender agent in relation to the Tender Offer.

The New Bonds have a tenor of four years and carry a floating rate interest of STIBOR 3M + 3.60%.

Vinge’s team consisted of Mikael Ståhl, Josefine Larsson and Lionardo Ojeda.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024